Abstract:mRNA vaccines have gained popularity over the last decade as a versatile tool for developing novel therapeutics. The recent success of coronavirus disease (COVID-19) mRNA vaccine has unlocked the potential of mRNA technology as a powerful therapeutic platform. In this review, we apprise the literature on the various types of cancer vaccines, the novel platforms available for delivery of the vaccines, the recent progress in the RNA-based therapies and the evolving role of mRNA vaccines for various cancer indications, along with a future strategy to treat the patients. Literature reveals that despite multifaceted challenges in the development of mRNA vaccines, the promising and durable efficacy of the RNA in pre-clinical and clinical studies deserves consideration. The introduction of mRNA-transfected DC vaccine is an approach that has gained interest for cancer vaccine development due to its ability to circumvent the necessity of DC isolation, ex vivo cultivation and re-infusion. The selection of appropriate antigen of interest remains one of the major challenges for cancer vaccine development. The rapid development and large-scale production of mRNA platform has enabled for the development of both personalized vaccines (mRNA 4157, mRNA 4650 and RO7198457) and tetravalent vaccines (BNT111 and mRNA-5671). In addition, mRNA vaccines combined with checkpoint modulators and other novel medications that reverse immunosuppression show promise, however further research is needed to discover which combinations are most successful and the best dosing schedule for each component. Each delivery route (intradermal, subcutaneous, intra tumoral, intranodal, intranasal, intravenous) has its own set of challenges to overcome, and these challenges will decide the best delivery method. In other words, while developing a vaccine design, the underlying motivation should be a reasonable combination of delivery route and format. Exploring various administration routes and delivery route systems has boosted the development of mRNA vaccines.

Evaluation of Application Value of mRNA Vaccines

mRNA vaccines in disease prevention and treatment

mRNA vaccines in the prevention and treatment of diseases

mRNA vaccine: a potential therapeutic strategy

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

The Recent Research Progress of the Tumor mRNA Vaccine

Advances and prospects of mRNA vaccines in cancer immunotherapy

mRNA vaccine in cancer therapy: Current advance and future outlook

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy

Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

The Potential of mRNA Vaccines to Fight Against Viruses

mRNA vaccination in breast cancer: current progress and future direction

mRNA-based cancer therapeutics

Cancer mRNA vaccines: clinical advances and future opportunities

mRNA-Based Cancer Vaccines: Advancements and Prospects

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

mRNA vaccine development and applications: A special focus on tumors (Review)

Path towards mRNA delivery for cancer immunotherapy from bench to bedside

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo